Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
February-2021 Volume 21 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
February-2021 Volume 21 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Exercise reduces hyperlipidemia‑induced kidney damage in apolipoprotein E‑deficient mice

  • Authors:
    • Chengsi Qian
    • Qin Yang
    • Lipeng Guo
    • Hupei Zhu
    • Xi You
    • Hongyang Liu
    • Yan Sun
  • View Affiliations / Copyright

    Affiliations: Department of Cardiology, Zhejiang Province Rongjun Hospital, Jiaxing, Zhejiang 314000, P.R. China, Department of Internal Medicine, The Affiliated Zhongshan Hospital of Dalian University, Dalian, Liaoning 116001, P.R. China, Department of Cardiology, Dalian Third People's Hospital Affiliated to Dalian Medical University, Dalian, Liaoning 116200, P.R. China, Department of Heart Intensive Care Unit, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116011, P.R. China
    Copyright: © Qian et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 153
    |
    Published online on: December 17, 2020
       https://doi.org/10.3892/etm.2020.9585
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Hyperlipidemia is a risk factor of kidney damage that can lead to chronic kidney disease. Studies have shown that exercise reduces kidney damage; however, the specific mechanisms underlying the protective effects of exercise remain unclear. For 12 weeks, 8‑week‑old male apolipoprotein E‑deficient (ApoE‑/‑) mice were randomly divided into four treatment groups (n=7/group) as follows: Mice fed a normal diet (ND group); mice fed a ND and exercised (ND + E group); mice fed a high‑fat diet (HD group); and mice fed a HD and exercised (HD + E group). Exercise training consisted of swimming for 40 min, 5 days/week. Metabolic parameters, such as low‑density lipoprotein‑cholesterol, total cholesterol and creatinine levels were higher in the ApoE‑/‑ HD mice compared with those in the ApoE‑/‑ HD + E mice. Serum levels of glutathione peroxidase and superoxide dismutase were significantly decreased in the HD group compared with those in the HD + E group. Significant pathological changes were observed in the HD + E group compared with in the HD group. Immunohistochemistry and immunoblotting revealed increased levels of oxidative stress (nuclear factor erythroid‑2‑related factor 2) and fibrosis (Smad3 and TGF‑β) markers in the ApoE‑/‑ HD group; however, the expression levels of these markers were significantly decreased in the ApoE‑/‑ HD + E group. Furthermore, NF‑κB expression in the HD + E group was significantly lower compared with that in the HD group. These results suggested that exercise may exert protective effects against kidney damage caused by hyperlipidemia.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Ding M, Si D, Zhang W, Feng Z, He M and Yang P: Red yeast rice repairs kidney damage and reduces inflammatory transcription factors in rat models of hyperlipidemia. Exp Ther Med. 8:1737–1744. 2014.PubMed/NCBI View Article : Google Scholar

2 

Peev V, Nayer A and Contreras G: Dyslipidemia, malnutrition, inflammation, cardiovascular disease and mortality in chronic kidney disease. Curr Opin Lipidol. 25:54–60. 2014.PubMed/NCBI View Article : Google Scholar

3 

Ruan XZ, Varghese Z and Moorhead JF: An update on the lipid nephrotoxicity hypothesis. Nat Rev Nephrol. 5:713–721. 2009.PubMed/NCBI View Article : Google Scholar

4 

Pei Z, Zhu L, Liu Y, Li N, Yang G and Liu H: Thymoquinone reduces kidney damage in apolipoprotein E-deficient mice fed a high-cholesterol diet. RSC Advances. 83:53002–53009. 2017.

5 

Pei Z, Okura T, Nagao T, Enomoto D, Kukida M, Tanino A, Miyoshi K, Kurata M and Higaki J: Osteopontin deficiency reduces kidney damage from hypercholesterolemia in Apolipoprotein E-deficient mice. Sci Rep. 6(28882)2016.PubMed/NCBI View Article : Google Scholar

6 

Zeynali F, Nematbakhsh M, Mojtahedi H, Poorshahnazari A, Talebi A, Pezeshki Z, Mazaheri S and Moslemi F: Protective role of aerobic exercise against cisplatin-induced nephrotoxicity in rats. Asian J Sports Med. 6(e24901)2015.PubMed/NCBI View Article : Google Scholar

7 

Cao G, González J, Müller A, Ottaviano G, Ambrosio G, Toblli JE and Milei J: Beneficial effect of moderate exercise in kidney of rat after chronic consumption of cola drinks. PLoS One. 11(e0152461)2016.PubMed/NCBI View Article : Google Scholar

8 

Braun K, Atmanspacher F, Schreckenberg R, Grgic I and Schlüter KD: Effect of free running wheel exercise on renal expression of parathyroid hormone receptor type 1 in spontaneously hypertensive rats. Physiol Rep. 6(e13842)2018.PubMed/NCBI View Article : Google Scholar

9 

Piedrahita JA, Zhang SH, Hagaman JR, Oliver PM and Maeda N: Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc Natl Acad Sci USA. 89:4471–4475. 1992.PubMed/NCBI View Article : Google Scholar

10 

Sastre C, Rubio-Navarro A, Buendía I, Gómez-Guerrero C, Blanco J, Mas S, Egido J, Blanco-Colio LM, Ortiz A and Moreno JA: Hyperlipidemia-associated renal damage decreases Klotho expression in kidneys from ApoE knockout mice. PLoS One. 8(e83713)2013.PubMed/NCBI View Article : Google Scholar

11 

Muñoz-García B, Moreno JA, López-Franco O, Sanz AB, Martín-Ventura JL, Blanco J, Jakubowski A, Burkly LC, Ortiz A, Egido J, et al: Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) enhances vascular and renal damage induced by hyperlipidemic diet in ApoE-knockout mice. Arterioscler Thromb Vasc Biol. 29:2061–2068. 2009.PubMed/NCBI View Article : Google Scholar

12 

Xu J, Zhu L, Liu H, Li M, Liu Y, Yang F and Pei Z: Thymoquinone reduces cardiac damage caused by hypercholesterolemia in apolipoprotein E-deficient mice. Lipids Health Dis. 17(173)2018.PubMed/NCBI View Article : Google Scholar

13 

Hong X, Zhao X, Wang G, Zhang Z, Pei H and Liu Z: Luteolin treatment protects against renal ischemia reperfusion injury in rats. Mediators Inflamm. 2017(9783893)2017.PubMed/NCBI View Article : Google Scholar

14 

Shingu C, Koga H, Hagiwara S, Matsumoto S, Goto K, Yokoi I and Noguchi T: Hydrogen-rich saline solution attenuates renal ischemia-reperfusion injury. J Anesth. 24:569–574. 2010.PubMed/NCBI View Article : Google Scholar

15 

Rasband WS: ImageJ, U.S. National Institutes of Health, Bethesda, MD, 1997-2018.

16 

Faran SA, Asghar S, Khalid SH, Khan IU, Asif M, Khalid I, Gohar UF and Hussain T: Hepatoprotective and renoprotective properties of lovastatin-loaded ginger and garlic oil nanoemulsomes: Insights into serum biological parameters. Medicina (Kaunas). 55(579)2019.PubMed/NCBI View Article : Google Scholar

17 

Schaeffner ES, Kurth T, Curhan GC, Glynn RJ, Rexrode KM, Baigent C, Buring JE and Gaziano JM: Cholesterol and the risk of renal dysfunction in apparently healthy men. J Am Soc Nephrol. 14:2084–2091. 2003.PubMed/NCBI

18 

Himmelfarb J and Hakim RM: Oxidative stress in uremia. Curr Opin Nephrol Hypertens. 12:593–598. 2003.PubMed/NCBI View Article : Google Scholar

19 

Vaziri ND: Roles of oxidative stress and antioxidant therapy in chronic kidney disease and hypertension. Curr Opin Nephrol Hypertens. 13:93–99. 2004.PubMed/NCBI View Article : Google Scholar

20 

Blokhina O, Virolainen E and Fagerstedt KV: Antioxidants, oxidative damage and oxygen deprivation stress: A review. Ann Bot. 91:179–194. 2003.PubMed/NCBI View Article : Google Scholar

21 

Deepa PR and Varalakshmi P: Favourable modulation of the inflammatory changes in hypercholesterolemic atherogenesis by a low-molecular-weight heparin derivative. Int J Cardiol. 106:338–347. 2006.PubMed/NCBI View Article : Google Scholar

22 

Scheuer H, Gwinner W, Hohbach J, Gröne EF, Brandes RP, Malle E, Olbricht CJ, Walli AK and Gröne HJ: Oxidant stress in hyperlipidemia-induced renal damage. Am J Physiol Renal Physiol. 278:F63–F74. 2000.PubMed/NCBI View Article : Google Scholar

23 

Napoli C and Lerman LO: Involvement of oxidation-sensitive mechanisms in the cardiovascular effects of hypercholesterolemia. Mayo Clin Proc. 76:619–631. 2001.PubMed/NCBI View Article : Google Scholar

24 

Kaplowitz N: Mechanisms of liver cell injury. J Hepatol. 32 (Suppl 1):39–47. 2000.PubMed/NCBI View Article : Google Scholar

25 

Loboda A, Damulewicz M, Pyza E, Jozkowicz A and Dulak J: Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: An evolutionarily conserved mechanism. Cell Mol Life Sci. 73:3221–3247. 2016.PubMed/NCBI View Article : Google Scholar

26 

Periyasamy P and Shinohara T: Age-related cataracts: Role of unfolded protein response, Ca2+ mobilization, epigenetic DNA modifications, and loss of Nrf2/Keap1 dependent cytoprotection. Prog Retin Eye Res. 60:1–19. 2017.PubMed/NCBI View Article : Google Scholar

27 

Calkins MJ, Johnson DA, Townsend JA, Vargas MR, Dowell JA, Williamson TP, Kraft AD, Lee JM, Li J and Johnson JA: The Nrf2/ARE pathway as a potential therapeutic target in neurodegenerative disease. Antioxid Redox Signal. 11:497–508. 2009.PubMed/NCBI View Article : Google Scholar

28 

Petri S, Körner S and Kiaei M: Nrf2/ARE signaling pathway: Key mediator in oxidative stress and potential therapeutic target in ALS. Neurol Res Int. 2012(878030)2012.PubMed/NCBI View Article : Google Scholar

29 

Ishikawa Y, Gohda T, Tanimoto M, Omote K, Furukawa M, Yamaguchi S, Murakoshi M, Hagiwara S, Horikoshi S, Funabiki K, et al: Effect of exercise on kidney function, oxidative stress, and inflammation in type 2 diabetic KK-Ay mice. Exp Diabetes Res. 2012(702948)2012.PubMed/NCBI View Article : Google Scholar

30 

Campanholle G, Ligresti G, Gharib SA and Duffield JS: Cellular mechanisms of tissue fibrosis. 3. Novel mechanisms of kidney fibrosis. Am J Physiol Cell Physiol. 304:C591–C603. 2013.PubMed/NCBI View Article : Google Scholar

31 

Jeong SI, Kim KJ, Choo YK, Keum KS, Choi BK and Jung KY: Phytolacca americana inhibits the high glucose-induced mesangial proliferation via suppressing extracellular matrix accumulation and TGF-beta production. Phytomedicine. 11:175–181. 2004.PubMed/NCBI View Article : Google Scholar

32 

Meng XM, Nikolic-Paterson DJ and Lan HY: TGF-β: The master regulator of fibrosis. Nat Rev Nephrol. 12:325–338. 2016.PubMed/NCBI View Article : Google Scholar

33 

Domino M, Jasinski T, Kautz E, Juszczuk-Kubiak E, Ferreira-Dias G, Zabielski R, Sady M and Gajewski Z: Expression of genes involved in the NF-κB-dependent pathway of the fibrosis in the mare endometrium. Theriogenology. 147:18–24. 2020.PubMed/NCBI View Article : Google Scholar

34 

Luedde T and Schwabe RF: NF-κB in the liver--linking injury, fibrosis and hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 8:108–118. 2011.PubMed/NCBI View Article : Google Scholar

35 

Umezawa K: Possible role of peritoneal NF-κB in peripheral inflammation and cancer: Lessons from the inhibitor DHMEQ. Biomed Pharmacother. 65:252–259. 2011.PubMed/NCBI View Article : Google Scholar

36 

Lind DS, Hochwald SN, Malaty J, Rekkas S, Hebig P, Mishra G, Moldawer LL, Copeland EM III and Mackay S: Nuclear factor-kappa B is upregulated in colorectal cancer. Surgery. 130:363–369. 2001.PubMed/NCBI View Article : Google Scholar

37 

Sosińska P, Baum E, Maćkowiak B, Staniszewski R, Jasinski T, Umezawa K and Bręborowicz A: Inhibition of NF-kappaB with Dehydroxymethylepoxyquinomicin modifies the function of human peritoneal mesothelial cells. Am J Transl Res. 8:5756–5765. 2016.PubMed/NCBI

38 

Sun L, Zhang S, Chang Q and Tan J: Establishment and comparison of different intrauterine adhesion modelling procedures in rats. Reprod Fertil Dev. 31(1360)2019.PubMed/NCBI View Article : Google Scholar

39 

Mann DA and Marra F: Fibrogenic signalling in hepatic stellate cells. J Hepatol. 52:949–950. 2010.PubMed/NCBI View Article : Google Scholar

40 

Zhang C, Kong X, Ning G, Liang Z, Qu T, Chen F, Cao D, Wang T, Sharma HS and Feng S: All-trans retinoic acid prevents epidural fibrosis through NF-κB signaling pathway in post-laminectomy rats. Neuropharmacology. 79:275–281. 2014.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Qian C, Yang Q, Guo L, Zhu H, You X, Liu H and Sun Y: Exercise reduces hyperlipidemia‑induced kidney damage in apolipoprotein E‑deficient mice. Exp Ther Med 21: 153, 2021.
APA
Qian, C., Yang, Q., Guo, L., Zhu, H., You, X., Liu, H., & Sun, Y. (2021). Exercise reduces hyperlipidemia‑induced kidney damage in apolipoprotein E‑deficient mice. Experimental and Therapeutic Medicine, 21, 153. https://doi.org/10.3892/etm.2020.9585
MLA
Qian, C., Yang, Q., Guo, L., Zhu, H., You, X., Liu, H., Sun, Y."Exercise reduces hyperlipidemia‑induced kidney damage in apolipoprotein E‑deficient mice". Experimental and Therapeutic Medicine 21.2 (2021): 153.
Chicago
Qian, C., Yang, Q., Guo, L., Zhu, H., You, X., Liu, H., Sun, Y."Exercise reduces hyperlipidemia‑induced kidney damage in apolipoprotein E‑deficient mice". Experimental and Therapeutic Medicine 21, no. 2 (2021): 153. https://doi.org/10.3892/etm.2020.9585
Copy and paste a formatted citation
x
Spandidos Publications style
Qian C, Yang Q, Guo L, Zhu H, You X, Liu H and Sun Y: Exercise reduces hyperlipidemia‑induced kidney damage in apolipoprotein E‑deficient mice. Exp Ther Med 21: 153, 2021.
APA
Qian, C., Yang, Q., Guo, L., Zhu, H., You, X., Liu, H., & Sun, Y. (2021). Exercise reduces hyperlipidemia‑induced kidney damage in apolipoprotein E‑deficient mice. Experimental and Therapeutic Medicine, 21, 153. https://doi.org/10.3892/etm.2020.9585
MLA
Qian, C., Yang, Q., Guo, L., Zhu, H., You, X., Liu, H., Sun, Y."Exercise reduces hyperlipidemia‑induced kidney damage in apolipoprotein E‑deficient mice". Experimental and Therapeutic Medicine 21.2 (2021): 153.
Chicago
Qian, C., Yang, Q., Guo, L., Zhu, H., You, X., Liu, H., Sun, Y."Exercise reduces hyperlipidemia‑induced kidney damage in apolipoprotein E‑deficient mice". Experimental and Therapeutic Medicine 21, no. 2 (2021): 153. https://doi.org/10.3892/etm.2020.9585
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team